Literature DB >> 23277078

Clarifying haplotype ambiguity of NAT2 in multi-national cohorts.

Silvia Selinski1, Meinolf Blaszkewicz, Jose A G Agundez, Carmen Martinez, Elena Garcia-Martin, Jan G Hengstler, Klaus Golka.   

Abstract

N-Acetyltransferase 2 (NAT2) is the key enzyme in aromatic amine metabolism. NAT2 genotyping requires a subsequent determination of the haplotype pairs (formerly: alleles) to derive the acetylation status. The chromosomal phase of the single nucleotide polymorphisms (SNPs) is unclear for about 2/3 of the genotypes. We investigated NAT2 genotypes of 1,234 bladder cancer cases and 2,207 controls from Germany, Hungary, Pakistan and Venezuela plus 696 further German cancer cases. We reconstructed NAT2 haplotypes using PHASE v2.1.1. We analysed if the variability of the NAT2 haplotypes affected the haplotype reconstruction. Furthermore, we compared population haplotype frequencies in three Caucasian control cohorts (German, Hungarian, Spanish), in Pakistanis and Venezuelans and the impact on bladder cancer. We conclude that a common haplotype reconstruction is feasible, enhances precision and reliability. Hungarian controls showed the largest intra-ethnic variability whereas the Pakistanis showed a haplotype distribution typical for Caucasians. The main differences could be observed for the slow haplotypes *5B, *6A and *7B. The association of slow NAT2 genotypes with bladder cancer risk was most prominent in the Venezuelan study group.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23277078     DOI: 10.2741/s399

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  3 in total

1.  Impact of urinary bladder cancer risk variants on prognosis and survival.

Authors:  Silvia Selinski
Journal:  EXCLI J       Date:  2014-11-28       Impact factor: 4.068

2.  The post GWAS era: strategies to identify gene-gene and gene-environment interactions in urinary bladder cancer.

Authors:  Silvia Selinski
Journal:  EXCLI J       Date:  2014-11-03       Impact factor: 4.068

3.  Highlight report: Functional consequences of urinary bladder cancer risk variants.

Authors:  Silvia Selinski
Journal:  EXCLI J       Date:  2013-12-05       Impact factor: 4.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.